Targeting TB elimination: Supplying MDR-TB medication to patients worldwide
Tuberculosis (TB) is one of the oldest and most persistent diseases in the world.
Even today, an estimated one-third of the world’s population is latently infected with TB bacteria.*1
Despite being curable, TB surpasses HIV/ AIDS as the most-deadly infectious disease.*2
In 2015 alone, 10.4 million people developed TB, and 1.8 million died from it.*2 Global progress in eliminating the disease is threatened by the spread of drug-resistant bacteria.*3